QIAGEN N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.61 USD | +0.07% |
|
+1.47% | -2.60% |
| May. 08 | Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics | MT |
| May. 07 | QIAGEN Partners with FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 9.67B | ||||||
| 44.96B | - | |||||
| 42.65B | ||||||
| 41.85B | ||||||
| 29.04B | ||||||
| 26.08B |
- Stock Market
- Equities
- QGEN Stock
- Charts Qiagen N.V.
- Sector Chart